Jayme E Locke1, Rhiannon D Reed2, Allan B Massie3, Paul A MacLennan2, Deirdre Sawinski4, Vineeta Kumar2, Jon J Snyder5, Alexis J Carter2, Brittany A Shelton2, Margaux N Mustian2, Cora E Lewis6, Dorry L Segev3. 1. University of Alabama at Birmingham School of Medicine, Comprehensive Transplant Institute, Birmingham, AL. Electronic address: jlocke@uabmc.edu. 2. University of Alabama at Birmingham School of Medicine, Comprehensive Transplant Institute, Birmingham, AL. 3. Johns Hopkins University School of Medicine, Baltimore, MD. 4. University of Pennsylvania School of Medicine, Philadelphia, PA. 5. Scientific Registry of Transplant Recipients, Minneapolis, MN. 6. University of Alabama at Birmingham School of Medicine, Department of Medicine, Division of Preventive Medicine, Birmingham, AL.
Abstract
BACKGROUND: Body mass index of living kidney donors has increased substantially. Determining candidacy for live kidney donation among obese individuals is challenging because many donation-related risks among this subgroup remain unquantified, including even basic postdonation mortality. METHODS: We used data from the Scientific Registry of Transplant Recipients linked to data from the Centers for Medicare and Medicaid Services to study long-term mortality risk associated with being obese at the time of kidney donation among 119,769 live kidney donors (1987-2013). Donors were followed for a maximum of 20 years (interquartile range 6.0-16.0). Cox proportional hazards estimated the risk of postdonation mortality by obesity status at donation. Multiple imputation accounted for missing obesity data. RESULTS: Obese (body mass index ≥ 30) living kidney donors were more likely male, African American, and had higher blood pressure. The estimated risk of mortality 20 years after donation was 304.3/10,000 for obese and 208.9/10,000 for nonobese living kidney donors. Adjusting for age, sex, race/ethnicity, blood pressure, baseline estimated glomerular filtration rate, relationship to recipient, smoking, and year of donation, obese living kidney donors had a 30% increased risk of long-term mortality compared with their nonobese counterparts (adjusted hazard ratio: 1.32, 95% CI: 1.09-1.60, P = .006). The impact of obesity on mortality risk did not differ significantly by sex, race or ethnicity, biologic relationship, baseline estimated glomerular filtration rate, or among donors who did and did not develop postdonation kidney failure. CONCLUSION: These findings may help to inform selection criteria and discussions with obese persons considering living kidney donation.
BACKGROUND: Body mass index of living kidney donors has increased substantially. Determining candidacy for live kidney donation among obese individuals is challenging because many donation-related risks among this subgroup remain unquantified, including even basic postdonation mortality. METHODS: We used data from the Scientific Registry of Transplant Recipients linked to data from the Centers for Medicare and Medicaid Services to study long-term mortality risk associated with being obese at the time of kidney donation among 119,769 live kidney donors (1987-2013). Donors were followed for a maximum of 20 years (interquartile range 6.0-16.0). Cox proportional hazards estimated the risk of postdonation mortality by obesity status at donation. Multiple imputation accounted for missing obesity data. RESULTS:Obese (body mass index ≥ 30) living kidney donors were more likely male, African American, and had higher blood pressure. The estimated risk of mortality 20 years after donation was 304.3/10,000 for obese and 208.9/10,000 for nonobese living kidney donors. Adjusting for age, sex, race/ethnicity, blood pressure, baseline estimated glomerular filtration rate, relationship to recipient, smoking, and year of donation, obese living kidney donors had a 30% increased risk of long-term mortality compared with their nonobese counterparts (adjusted hazard ratio: 1.32, 95% CI: 1.09-1.60, P = .006). The impact of obesity on mortality risk did not differ significantly by sex, race or ethnicity, biologic relationship, baseline estimated glomerular filtration rate, or among donors who did and did not develop postdonation kidney failure. CONCLUSION: These findings may help to inform selection criteria and discussions with obesepersons considering living kidney donation.
Authors: Lesley A Stevens; Christopher H Schmid; Yaping L Zhang; Josef Coresh; Jane Manzi; Richard Landis; Omran Bakoush; Gabriel Contreras; Saul Genuth; Goran B Klintmalm; Emilio Poggio; Peter Rossing; Andrew D Rule; Matthew R Weir; John Kusek; Tom Greene; Andrew S Levey Journal: Nephrol Dial Transplant Date: 2009-09-30 Impact factor: 5.992
Authors: Jayme E Locke; Haiyan Qu; Richard Shewchuk; Roslyn B Mannon; Robert Gaston; Dorry L Segev; Elinor C Mannon; Michelle Y Martin Journal: Clin J Am Soc Nephrol Date: 2015-01-29 Impact factor: 8.237
Authors: Dorry L Segev; Abimereki D Muzaale; Brian S Caffo; Shruti H Mehta; Andrew L Singer; Sarah E Taranto; Maureen A McBride; Robert A Montgomery Journal: JAMA Date: 2010-03-10 Impact factor: 56.272
Authors: Krista L Lentine; Bertram L Kasiske; Andrew S Levey; Patricia L Adams; Josefina Alberú; Mohamed A Bakr; Lorenzo Gallon; Catherine A Garvey; Sandeep Guleria; Philip Kam-Tao Li; Dorry L Segev; Sandra J Taler; Kazunari Tanabe; Linda Wright; Martin G Zeier; Michael Cheung; Amit X Garg Journal: Transplantation Date: 2017-08 Impact factor: 4.939
Authors: Chi-yuan Hsu; Charles E McCulloch; Carlos Iribarren; Jeanne Darbinian; Alan S Go Journal: Ann Intern Med Date: 2006-01-03 Impact factor: 25.391
Authors: Daniel Abramowicz; Pierre Cochat; Frans H J Claas; Uwe Heemann; Julio Pascual; C Dudley; Paul Harden; Marivonne Hourmant; Umberto Maggiore; Maurizio Salvadori; Goce Spasovski; Jean-Paul Squifflet; Jürg Steiger; Armando Torres; Ondrej Viklicky; Martin Zeier; Raymond Vanholder; Wim Van Biesen; Evi Nagler Journal: Nephrol Dial Transplant Date: 2014-07-09 Impact factor: 5.992
Authors: Morgan E Grams; Yingying Sang; Andrew S Levey; Kunihiro Matsushita; Shoshana Ballew; Alex R Chang; Eric K H Chow; Bertram L Kasiske; Csaba P Kovesdy; Girish N Nadkarni; Varda Shalev; Dorry L Segev; Josef Coresh; Krista L Lentine; Amit X Garg Journal: N Engl J Med Date: 2015-11-06 Impact factor: 91.245
Authors: S J Taler; E E Messersmith; A B Leichtman; B W Gillespie; C E Kew; M D Stegall; R M Merion; A J Matas; H N Ibrahim Journal: Am J Transplant Date: 2012-11-08 Impact factor: 8.086
Authors: Hassan N Ibrahim; Dina N Murad; Sean A Hebert; Horacio E Adrogue; Hana Nguyen; Duc T Nguyen; Arthur J Matas; Edward A Graviss Journal: J Am Soc Nephrol Date: 2021-10-21 Impact factor: 10.121
Authors: William P Martin; James White; Francisco J López-Hernández; Neil G Docherty; Carel W le Roux Journal: Front Endocrinol (Lausanne) Date: 2020-08-17 Impact factor: 5.555